Obviously presenting is different than attending. So it is a big deal for PMCB. You never know what investors can come out of this or potential partner. I do believe those partners are already in line but you never know who you will meet at ASCO. The place where only the big pharma gets to present. Now they are welcoming PMCB.
News 
Market Data 
Discover 
